Issue 54

May - June 2013

Article of the week:

Cross Talk

Finding breakthrough treatments: how do we fix the broken model?

Are dysfunctional relations between academia and industry hindering the process of turning progress in our understanding of cancer into truly effective treatments? Read More..

Every Friday, a new Article of the Week is posted on our website.
Please click here if you would like to receive our free weekly e-newsletter which highlights the weekly article.

 

RECENT COMMENTS

  • David Ryner (don't play with numbers): I agree with Duncan and thank you Kathy. I number myself amongst many who suffer from a cr [...]   »Read more
  • Duncan Jefferson (don't play with numbers): A very common sense article and one that should be taken on board by all in the Health "In [...]   »Read more
  • Ken Campbell (recording consultations): I am clinical information offider for a UK cancer charity. I often recommend to patients t [...]   »Read more
  • Frank (recording consultations): Yes I had a pt request a consultation with me - I am concerned about the medicolegal aspec [...]   »Read more
  • Nicola Nicolai, Lara Bellardita, Massimo Maffezzini, Tiziana Magnani, Riccardo Valdagni and the Prostate Cancer Program Multidisciplinary Team at Fondazione IRCCS Istituto Nazionale dei Tumori, Milan: The topic is of great interest, with good points in favour as well as against the referral [...]   »Read more
  • Marian marie: It was next to impossible to manage my Thyroid Cancer after I had a Thyroidectomy in 1976. [...]   »Read more
  • Paul CORNES (centralising cancer services): Thank you both - I enjoyed reading this. The best systematic review on the topic comes [...]   »Read more
  • Steven Vermeulen: I was diagnose with adenocarcinoma with unknown primary in Oct. 2009. I was 54 years old, [...]   »Read more
  • Wolfgang Grisold (cancer treatment: agesim): Thank you for raising this interesting issue. Personally , I have the impression that at l [...]   »Read more
  • Gloria Freilich (cancer treatment: ageism): In my experience, having worked in the field of breast cancer from l987 to 2008 in a Londo [...]   »Read more

The website is supported by an unrestricted educational grant provided by:

Founding sponsor

e-ESO.net

E-eso

Online educational resources Including e-grandrounds, weekly online meetings in collaboration with Nature Reviews Clinical Oncology - CME accredited!

Next live sessions:

GR245 - Multidisciplinary treatment of malignant thymoma

GR246 - New CNS Profilaxis and treatment in Nodal NHL. Evidence based recommendations

GR32 - Imaging in oncology – over a century of advances

CancerWorld invites you to visit:

E-eso
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
E-aso
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
 
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Boehringer Ingelheim, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Helsinn, Merck Serono, Novartis, Roche and Sanofi Aventis.